An elderly woman holding a little girl's hand, facing the sunset by the sea – #IkhthiraamgeUfaa #ThahuzeebuMujuthamau

State Pharma Expects Improvement in Medicine Availability by Early 2027

Inside State Pharma Medical Warehouse / Photo: Javiyani

State Pharma Managing Director Dr Shah Mahir has said the Maldives could see a significant improvement in medicine availability by early 2027 if the state-owned company’s current procurement and supply efforts continue at their present pace.

The country has experienced recurring shortages of essential medicines, with patients reporting difficulties obtaining prescribed drugs. The government established State Pharma to take over pharmaceutical procurement and distribution responsibilities previously managed by State Trading Organization (STO).

Speaking from the company’s warehouse on Tuesday, Dr Shah said weaknesses in supply-chain management had contributed to the shortages. Since taking charge in August, he said, his priority has been to establish the systems and infrastructure needed to improve how medicines are ordered, tracked and distributed.

Among the measures introduced are enterprise resource planning (ERP) software and a real-time monitoring system designed to track medicine stocks and product varieties across the country. According to Dr Shah, the systems will help State Pharma anticipate demand and submit procurement orders earlier.

He explained that pharmaceutical purchasing involves requirements that differ from those for ordinary goods, including regulatory controls and temperature-sensitive transport arrangements.

Manufacturers also do not necessarily keep sufficient quantities of every medicine ready for immediate shipment, he said. Large orders may need to be produced specifically for a buyer, adding to the time required before supplies can reach the Maldives.

State Pharma is now arranging medicine supplies for the coming year while overseeing a portfolio of more than 5,000 pharmaceutical products. Dr Shah said differing demand levels and expiry dates make procurement planning complex, with the immediate focus on restoring reliable access to essential medicines.

More than 600 types of medicine have been imported over the past four months, according to the managing director. He acknowledged that the volume remains inadequate and said the company is continuing efforts to replenish items that are running low.

Dr Shah expressed confidence that maintaining the current pace of work would allow the public to experience a noticeable improvement early next year. He said the company’s longer-term objective is to ensure that medicines needed by patients remain consistently available.

Medicine shortages have continued to place pressure on patients, some of whom must visit several pharmacies to obtain prescriptions. Others face additional out-of-pocket costs when required medicines are not covered under the Aasandha health insurance scheme.

Leave a Reply

Your email address will not be published. Required fields are marked *